| 摘要: |
| 本文针对心脑血管疾病的发病情况。从冠心病及心绞痛病原学出发,根据预防和治疗冠心病药物的类型和作用机理,从专利权保护的角度分析了临床常用单硝酸异山梨酯药物专利保护现状。为防治冠心病药物的生产企业进行市场评估、专利申请、知识产权保护提供了参考。 |
| 关键词: 冠心病 单硝酸异山梨酯 专利权 药物 |
| DOI:10.13506/j.cnki.jpr.2018.05.014 |
| 基金项目: |
|
|
|
| Analysis of isosorbide mononitrate and its patent protection |
| MA Qingwen,LIU Qingdong,ZHAO Wei,SHEN Qiangyu |
| (Lunan Pharmaceutical Group Corporation,Linyi 276006,China) |
| Abstract: |
| This article was compiled for the cardiovascular and cerebrovascular disease states.Based on the pathogenesis of coronary heart disease and angina pectoris, according to the type and mechanism of prevention and treatment of coronary heart disease,the status of patent protection of isosorbide mononitrate was analyzed from the perspective of patent protection.It provided reference in the market evaluation, patent application and intellectual property protection for the drug manufacturing enterprises。 |
| Key words: Coronary heart disease Isosorbide mononitrate Patent Drug |